Mechanistic Characterization of Calcium and ROS Induced Mitochondrial Dysfunction

钙和 ROS 诱导的线粒体功能障碍的机制表征

基本信息

  • 批准号:
    9203673
  • 负责人:
  • 金额:
    $ 24.9万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-09-16 至 2019-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): In the United States, there are more than 8 million people who have suffered from at least one acute myocardial infarction in their lifetime. One of the major injuries associated with myocardial infarction is lethal ischemia/reperfusion (I/R) injur. This type of injury manifests from a phenomenon known as mitochondrial permeability transition (MPT), a detrimental form of mitochondrial dysfunction. MPT results in myocardial apoptosis or necrosis and is linked to dysfunction in mitochondrial Ca2+ handling and oxidative stress. Only recently has MPT been accepted as being a physiological response to myocardial I/R injury, but there still remains a significant need to improve current clinical treatments. This proposal aims to quantify the biophysical phenomena and chemical kinetics associated with mitochondrial dysfunction and to elucidate the relationship between mitochondrial Ca2+ and ROS homeostasis with MPT induction under physiological and pathophysiological conditions, particularly I/R injury, in isolated guinea pig cardiac mitochondria. This synergistic computational/experimental approach will encompass computational modeling and experimental observation to help formulate and quantitatively test hypotheses related to mitochondrial dysfunction. In doing so, this study will facilitate a rational and mechanistic approach to identify new therapeutic targets and develop novel therapies to correct or prevent mitochondrial dysfunction under pathological conditions, particularly I/R injury. The main purpose of this project is to provide the Principal Investigator with assistance to establish his independence and obtain a tenure-track faculty position in order to setup a research program to elucidate the origin of mitochondrial dysfunction associated with mitochondrial Ca2+ dysregulation and oxidative stress. During the mentored phase, the applicant will develop the necessary experimental acumen to complement their modeling skill set and sustain an independent research career in the field of mitochondrial physiology and computational biology. The training will include operating state-of-the-art equipment to characterize the mitochondrial Ca2+ sequestration system and develop a model of ROS homeostasis for cardiac mitochondria. During the independent phase, the applicant will apply his recent experimental training to determine the mechanism(s) responsible for the loss in mitochondrial Ca2+ and ROS homeostasis and characterize how dysregulation in these signaling constituents lead to MPT resulting in catastrophic cellular and organ system failure. The work laid out in this project will move us one step closer to understanding the pathophysiology of MPT, and the model developed will be an invaluable tool for the development of novel therapeutics to help prevent or assuage the detrimental consequences of unmitigated MPT induction.
描述(申请人提供):在美国,有800多万人一生中至少遭受过一次急性心肌梗死。与心肌梗死相关的主要损伤之一是致死性缺血/再灌注损伤。这种类型的损伤表现为一种称为线粒体通透性转变(MPT)的现象,这是线粒体功能障碍的一种有害形式。MPT可导致心肌细胞凋亡或坏死,并与线粒体钙处理功能障碍和氧化应激有关。直到最近,MPT才被认为是对心肌I/R损伤的一种生理反应,但仍有必要改进当前的临床治疗。本研究旨在量化与线粒体功能障碍相关的生物物理现象和化学动力学,并阐明在生理和病理生理条件下,尤其是I/R损伤条件下,线粒体Ca~(2+)和ROS稳态与MPT诱导的关系。这种协同的计算/实验方法将包括计算建模和实验观察,以帮助制定和定量测试与线粒体功能障碍相关的假说。通过这样做,本研究将促进一种理性和机械性的方法来确定新的治疗靶点,并开发新的治疗方法来纠正或预防病理条件下的线粒体功能障碍,特别是I/R损伤。这个项目的主要目的是帮助首席研究员建立他的独立性,并获得一个终身教职的职位,以便建立一个研究计划,以阐明与线粒体钙调节失调和氧化应激相关的线粒体功能障碍的起源。在指导阶段,申请者将发展必要的实验敏锐性,以补充他们的建模技能,并在线粒体生理学和计算生物学领域维持独立的研究生涯。培训将包括操作最先进的设备,以确定线粒体钙隔离系统的特征,并开发心肌线粒体的ROS稳态模型。在独立阶段,申请者将应用他最近的实验培训来确定线粒体钙离子和ROS稳态丧失的机制(S),并描述这些信号成分的失调是如何导致MPT导致灾难性的细胞和器官系统衰竭的。本项目中的工作将使我们更接近理解MPT的病理生理学,所开发的模型将是开发新疗法的宝贵工具,以帮助预防或减轻未减轻的MPT诱导的有害后果。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jason N Bazil其他文献

Jason N Bazil的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jason N Bazil', 18)}}的其他基金

Mechanistic Characterization of Calcium and ROS Induced Mitochondrial Dysfunction
钙和 ROS 诱导的线粒体功能障碍的机制表征
  • 批准号:
    9222039
  • 财政年份:
    2014
  • 资助金额:
    $ 24.9万
  • 项目类别:
Mechanistic Characterization of Calcium and ROS Induced Mitochondrial Dysfunction
钙和 ROS 诱导的线粒体功能障碍的机制表征
  • 批准号:
    8618394
  • 财政年份:
    2014
  • 资助金额:
    $ 24.9万
  • 项目类别:
Mechanistic Characterization of Calcium and ROS Induced Mitochondrial Dysfunction
钙和 ROS 诱导的线粒体功能障碍的机制表征
  • 批准号:
    8927675
  • 财政年份:
    2014
  • 资助金额:
    $ 24.9万
  • 项目类别:

相似海外基金

Improving Acute Disease Management for Patients with Alzheimer's Disease and Related Dementias
改善阿尔茨海默病和相关痴呆症患者的急性疾病管理
  • 批准号:
    10712647
  • 财政年份:
    2001
  • 资助金额:
    $ 24.9万
  • 项目类别:
INDUCTION OF ACUTE DISEASE IN MACAQUES BY NEF GENE VARIANT OF SIVMAC239
SIVMAC239 的 NEF 基因变体在猕猴中诱导急性疾病
  • 批准号:
    6247642
  • 财政年份:
    1997
  • 资助金额:
    $ 24.9万
  • 项目类别:
INDUCTION OF ACUTE DISEASE IN MACAQUES BY NEF GENE VARIANT OF SIVMAC239
SIVMAC239 的 NEF 基因变体在猕猴中诱导急性疾病
  • 批准号:
    3718999
  • 财政年份:
  • 资助金额:
    $ 24.9万
  • 项目类别:
Neurophysiological alterations in multiple sclerosis patients during acute disease acivity
多发性硬化症患者急性疾病活动期间的神经生理学变化
  • 批准号:
    465668867
  • 财政年份:
  • 资助金额:
    $ 24.9万
  • 项目类别:
    Research Grants
SIVMAC 1NEF ALLELE: LYMPHOCYTE ACTIVATION & ACUTE DISEASE IN MACAQUE MONKEYS
SIVMAC 1NEF 等位基因:淋巴细胞激活
  • 批准号:
    3719026
  • 财政年份:
  • 资助金额:
    $ 24.9万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了